(410 ILCS 405/2)
(from Ch. 111 1/2, par. 6952)
The General Assembly finds that dementia is a general term for cognitive decline caused by various diseases and conditions that result in damaged brain cells or connections between brain cells. Alzheimer's disease is the most common type of dementia, caused by physical changes in the brain and accounting for 60% to 80% of cases. There are many other causes of dementia, known here as related disorders. Today Alzheimer's disease affects
Americans; approximately 210,000
citizens have Alzheimer's disease. The General Assembly also recognizes that the incidence of Alzheimer's disease is rising and expected to reach 240,000 in Illinois by 2025. The General Assembly finds that Medicaid costs for individuals with Alzheimer's disease are 9 times higher than the costs for a person without Alzheimer's disease in the same age group and that 71% of all Illinois nursing home residents have some degree of cognitive impairment, with more than half of that group having moderate to severe cognitive decline.
The General Assembly also finds that Alzheimer's is not a normal part of aging, although the greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older. But Alzheimer's is not just a disease of old age. Up to 5% of people with the disease have early-onset Alzheimer's (also known as younger-onset), which often appears when someone is in their forties or fifties. It is the opinion of the General
Assembly that Alzheimer's disease and related disorders cause serious
financial, social, and emotional hardships on persons with Alzheimer's disease or related disorders and their families
of such a major consequence that it is essential for the State to develop and
implement policies, plans, programs and services to alleviate such hardships.
The General Assembly recognizes that there is no known cause or cure
of Alzheimer's disease at this time, and that it can progress
over an extended period of time and to such a degree that a person with Alzheimer's disease dies from Alzheimer's disease. The General Assembly recognizes that Alzheimer's disease is the sixth leading cause of death across all ages in the United States and the fifth leading cause of death for those aged 65 or older. It is the intent of the General
Assembly, through implementation of this Act, to establish a program for
the conduct of research regarding the cause, cure and treatment of Alzheimer's
disease and related disorders; and, through
the establishment of Regional Alzheimer's Disease Assistance Centers and
a comprehensive, Statewide system of regional and community-based services,
to provide for the identification, evaluation, diagnosis, referral and
treatment of individuals with Alzheimer's disease or related disorders. It is also the intent of the General Assembly to provide adequate and appropriate State policy and regulations to ensure that Illinois persons with Alzheimer's disease and related disorders are able to maintain their quality of life and their dignity as they progress through the course of the disease.
(Source: P.A. 97-768, eff. 1-1-13.)
(410 ILCS 405/3)
(from Ch. 111 1/2, par. 6953)
As used in this Act:
(a) "Alzheimer's disease" or "Alzheimer's" or "AD" means the most common form of dementia that causes problems with memory, thinking, and behavior. Symptoms usually develop slowly and get worse over time, becoming severe enough to interfere with daily tasks. Symptoms include a decline in memory and the loss of function in at least one other cognitive ability, such as the ability to generate coherent speech or understand written or spoken language; the ability to recognize or identify objects; the ability to execute motor activities; or the ability to think abstractly.
(a-5) "Dementia" means cognitive decline, including a loss of memory and other mental abilities severe enough to interfere with daily life.
(a-10) "Related disorders" or "related dementias" means any other form of dementia that is not caused by Alzheimer's disease.
(a-15) "Dementia-capable State" means that the State of Illinois and its long-term care services, community-based services, and dementia support systems have:
(1) the ability to identify people with dementia and
(2) information, referral, and service coordination
systems that provide person-centered services to people with dementia and their caregivers;
(3) eligibility criteria for public programs that are
equitable for people with dementia;
(4) coverage of services that people with dementia
and their caregivers are likely to use;
(5) a professional caregiving workforce that knows
about Alzheimer's disease and other dementias and how to serve that population and their caregivers; and
(6) quality assurance systems that take into account
the unique needs of people with dementia and their caregivers.
(b) "Regional Alzheimer's Disease Assistance Center" or "Regional ADA
Center" means any postsecondary higher educational institution having
a medical school in affiliation with a medical center and having a National
Institutes of Health and National Institutes on Aging sponsored Alzheimer's
Disease Core Center.
Any Regional ADA Center which was designated as having a National Alzheimer's
Disease Core Center but no longer carries such designation shall continue to
serve as a Regional ADA Center.
(c) "Primary Alzheimer's provider" means a licensed hospital, a medical
center under the supervision of a physician licensed to practice medicine
in all of its branches, or a medical center that provides medical
consultation, evaluation, referral and treatment to persons who may be or
who have been diagnosed as individuals with Alzheimer's disease or related
disorders pursuant to policies, standards, criteria and procedures adopted
under an affiliation agreement with a Regional ADA Center under this Act.
(d) "Alzheimer's disease assistance network" or "ADA network" means the
various health, mental health and social services agencies that provide
referral, treatment and support services under standards and plans
adopted and implemented in conjunction with a Regional ADA Center.
(e) "ADA Advisory Committee" or "Advisory Committee" or "Committee" means
the Alzheimer's Disease Advisory Committee created under Section 6 of this Act.
(f) "Department" means the Illinois Department of Public Health.
(Source: P.A. 97-768, eff. 1-1-13.)
(410 ILCS 405/4)
(from Ch. 111 1/2, par. 6954)
Development of standards for a service network and
designation of regional centers and primary providers. By January 1, 1987, the
Department, in consultation with the Advisory Committee, shall develop
standards for the conduct of research and for the identification,
evaluation, diagnosis, referral and treatment of individuals with Alzheimer's
disease and related disorders and their families through the ADA network of
designated regional centers and other providers of service
under this Act. Such standards shall include all of the following:
(a) A description of the specific populations and
geographic areas to be served through ADA networks that may be established under this Act.
(b) Standards, criteria and procedures for
designation of Regional ADA Centers, which ensure the provision of quality care to a broad segment of the population through on-site facilities and services and through a network of primary Alzheimer's providers and other providers of service that may be available within the service area defined by the Department. At least 2 Regional ADA Centers shall be conveniently located to serve the Chicago metropolitan area and at least one Regional ADA Center shall be conveniently located to serve the balance of the State. The Regional ADA Centers shall provide at least the following:
(1) comprehensive diagnosis and treatment
facilities and services which have (i) professional medical staff specially-trained in geriatric medicine, neurology, psychiatry and pharmacology, and the detection, diagnosis and treatment of Alzheimer's disease and related disorders, (ii) sufficient support staff who are trained as caregivers to individuals with Alzheimer's disease and related disorders, (iii) appropriate and adequate equipment necessary for diagnosis and treatment, and (iv) such other support services, staff and equipment as may be required;
(2) consultation and referral services for
individuals with AD and their families or demonstrated instances of referral to consultation and referral services provided by organizations and agencies specializing in Alzheimer's disease and related disorders for those affected to ensure informed consent to treatment and to assist them in obtaining necessary assistance and support services through primary Alzheimer's providers and various private and public agencies that may otherwise be available to provide services under this Act;
(3) research programs and facilities to assist
faculty and students in discovering the cause of and the diagnosis, cure and treatment for Alzheimer's disease and related disorders;
(4) training, consultation and continuing
education for caregivers or demonstrated instances of referral to training, consultation, and continuing education provided by organizations and agencies specializing in Alzheimer's disease and related disorders for those affected, including families of those who are affected by Alzheimer's disease and related disorders;
(5) centralized data collection, processing and
storage that will serve as a clearinghouse of information to assist individuals with AD, families and ADA Resources, and to facilitate research; and
(6) programs of scientific and medical research
in relation to Alzheimer's disease and related disorders that are designed and conducted in a manner that may enable such center to qualify for Federal financial participation in the cost of such programs.
(c) Procedures for recording and reporting research
and treatment results by primary Alzheimer's providers and other affiliated providers of service that are within the ADA network to the Regional ADA Center and to the Department.
(d) Policies, procedures and minimum standards and
criteria to be included in affiliation agreements between primary Alzheimer's providers and the Regional ADA Center in the conduct of any research and in the diagnosis, referral and treatment of individuals with Alzheimer's disease and related disorders and their families.
(e) Policies, procedures, standards and criteria,
including medical and financial eligibility factors, governing admission to and utilization of the programs, facilities and services available through the ADA network by persons who may be or who have been diagnosed as having Alzheimer's disease or a related disorder, including forms and procedures for obtaining necessary patient consents to participation in research, and in the reporting and processing of appropriate information in a patient's medical records in relation to consultations, referrals and treatments by the various providers of service within the ADA network.
(Source: P.A. 97-768, eff. 1-1-13.)
(410 ILCS 405/5)
(from Ch. 111 1/2, par. 6955)
State ADA Plan.
By January 1, 2014, and every 3 years
thereafter, the Department shall prepare a State Alzheimer's Disease
Assistance Plan in consultation with the Advisory Committee to guide
research, diagnosis, referral and treatment services within each service
area described by the Department. To ensure meaningful input by stakeholders into the plan, the Department or members of the General Assembly or other interested parties may hold public hearings at locations throughout the State for input by consumers and providers of care. The Department or members of the General Assembly or other interested parties may also utilize technological means or work with advocacy organizations that have technological capability, such as Webcasts or online surveys, to gather feedback on recommendations from persons and families affected by Alzheimer's disease and the general public. State agencies with programs serving the population impacted by Alzheimer's may also present testimony at one of the State hearings to specify how they are meeting the needs of people with Alzheimer's. Various stakeholders, including related consumer organizations or advocacy organizations as well as individuals with Alzheimer's disease or a related disorder and caregivers of such individuals, may also be invited to provide public comment. The results of any public hearings held pursuant to this Section shall be presented to the Department in a format as determined by the Department to be included in the State Alzheimer's Disease Assistance Plan.
The plan shall incorporate any testimony that may be offered on the following topics:
(1) An assessment of the current and future impact
of Alzheimer's disease on Illinois residents.
(2) An examination of the existing industries,
services, and resources addressing the needs of persons with Alzheimer's, their families, and caregivers.
(3) The development of a strategy to mobilize a State
response to this public health crisis.
(4) Trends in State Alzheimer's population and needs,
including the changing population with dementia, including, but not limited to, the use of State surveillance data of persons with Alzheimer's disease for purposes of having proper estimates of the number of persons in the State with Alzheimer's disease.
(5) The current economic impact of Alzheimer's
disease and related disorders for the State, including the cost of direct and indirect care paid by Medicaid, other federal-State funded programs, the estimated direct and indirect costs of family caregiving, and the cost of Alzheimer's disease to businesses in Illinois.
(6) Existing services, resources, and capacity,
including, but not limited to, the:
(a) type, cost, and availability of dementia
(b) dementia-specific training requirements for
paid professionals at any level and in any provider setting (institutional or home or community based) engaged in the care of persons with dementia;
(c) quality care measures instituted in this
State for long-term care facilities; assisted living facilities; supportive living facilities; or any other residential program available for the care of persons with dementia;
(d) capacity of public safety and law enforcement
to respond to persons with Alzheimer's;
(e) availability of and amount spent by the State
on home and community-based resources for persons with Alzheimer's and related disorders and the availability of State-supported respite care to assist families;
(f) inventory of all residential options for
individuals with dementia in this State, including, but not limited to, long-term special care units for people with dementia, assisted living units for dementia, and supportive living units for dementia;
(g) inventory of geriatric-psychiatric units for
persons with behavior disorders associated with Alzheimer's and related disorders;
(h) specific efforts of State agencies directed
towards persons with Alzheimer's disease and related disorders and the agencies' estimation of resources that will be needed to meet an increased demand; and
(i) level of State support of Alzheimer's
research through Illinois universities or other institutions and the results of such investments reflected both in research outcomes and subsequent federal investment in research in Illinois.
(7) Recommended changes or additions to State
policies, including, but not limited to, directions for the provision of clear and coordinated services and supports to persons and families living with Alzheimer's and related disorders and strategies to address any identified gaps in services.
The plan shall also indicate the number of persons
served, the extent of services provided, and the resources required for the
delivery of services through the ADA networks established under this Act.
Such plan shall identify and describe the duties and accomplishments of
each Regional ADA Center, the primary Alzheimer's providers and other various
providers of service within the ADA network of the described service area.
The Department shall consult with and take into consideration the plans of
local and State comprehensive health planning agencies recognized under the
Comprehensive Health Planning Act, as well as recommendations regarding Alzheimer's disease and related disorders that may be included in the State Health Improvement Plan.
(Source: P.A. 97-768, eff. 1-1-13
(410 ILCS 405/6)
(from Ch. 111 1/2, par. 6956)
Alzheimer's Disease Advisory Committee.
(a) There is created the Alzheimer's
Disease Advisory Committee consisting of 17 voting members appointed by the
Director of the Department, as well as 5 nonvoting members as hereinafter
provided in this Section. The Director or his designee shall serve as one
of the 17 voting members and as
the Chairman of the Committee. Those appointed as voting members shall
include persons who are experienced in
research and the delivery of services to individuals with Alzheimer's disease or a related disorder and their families.
Such members shall include:
(1) one individual from a statewide association
dedicated to Alzheimer's care, support, and research;
(2) one individual from a non-governmental statewide
organization that advocates for seniors;
(3) the Dementia Coordinator of the Illinois
Department of Public Health, or the Dementia Coordinator's designee;
(4) one individual representing the Community Care
Program's Home and Community Services Division;
(5) one individual representing the Adult Protective
(6) 3 individuals from Alzheimer's Disease Assistance
(7) one individual from a statewide association
representing an adult day service organization;
(8) one individual from a statewide association
representing home care providers;
(9) one individual from a statewide trade
organization representing the interests of physicians licensed to practice medicine in all of its branches in Illinois;
(10) one individual representing long-term care
facilities licensed under the Nursing Home Care Act, an assisted living establishment licensed under the Assisted Living and Shared Housing Act, or supportive living facilities;
(11) one individual from a statewide association
representing the interests of social workers;
(12) one individual representing Area Agencies on
(13) the Medicaid Director of the Department of
Healthcare and Family Services, or the Medicaid Director's designee;
(14) one individual from a statewide association
representing health education and promotion and public health advocacy; and
(15) one individual with medical or academic
experience with early onset Alzheimer's disease or related disorders.
(b) In addition to the 17 voting members, the Directors of the following
State agencies or their designees who are qualified to represent each Department's programs and services for those with Alzheimer's disease or related disorders shall serve as nonvoting members:
Department on Aging, Department
of Healthcare and Family Services, Department of Public Health, Department of Human Services, and Guardianship and Advocacy Commission.
Each voting member appointed by the
Director of Public Health shall serve for a term of 2 years, and until his
successor is appointed and qualified. Members of the Committee shall not
be compensated but shall be reimbursed for expenses actually incurred in
the performance of their duties. Vacancies shall be filled in the same manner as
The Committee shall review all State programs and services provided by State agencies that are directed toward persons with Alzheimer's disease and related dementias, and by consensus recommend changes to improve the State's response to this serious health problem. Such recommendations shall be included in the State plan described in this Act.
(Source: P.A. 101-588, eff. 1-1-20